Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma-Reference-Cited by-同舟云学术

Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma

Published:2014-11-01 Issue:11 Volume:132 Page:1372
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Buitrago Emiliano¹,Lagomarsino Eduardo²,Mato Gabriel²,Schaiquevich Paula³

Affiliation:

1. Clinical Pharmacokinetics Unit, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina

2. Department of Pharmacy, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina

3. Clinical Pharmacokinetics Unit, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina3National Scientific and Technical Research Council (CONICET), Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RP-HPLC method combined with ultrafiltration for simultaneous analysis of Melphalan and Topotecan in human plasma samples;Journal of Chemical Metrology;2024-06-28

2. Therapy for Vitreous Seeding Caused by Retinoblastoma. A Review;Czech and Slovak Ophthalmology;2023-07-30

3. Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma;Journal of NeuroInterventional Surgery;2023-06-28

4. How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP);Pediatric Blood & Cancer;2023-04-14

5. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma;Ophthalmology Retina;2023-04